AKAN (Akanda) Wutah bathi ing taun lumaku

AKAN (Akanda Inc) - tandha merek perusahaan

Akanda generates revenue from the supply of legal cannabis to pharmacies in the UK and Germany. The relative EPS YoY trend clearly demonstrates profit dynamics, with the indicator remaining around 0.00. Prospects depend on European decriminalization and the development of e-commerce. However, the company is currently undergoing a rigorous debt restructuring and radical cost reductions for the sake of survival.

Wutah bathi ing taun lumaku Akanda Corp. (AKAN): kanggo periode 28.04.2023 - 12.11.2026

Rincian metrik keuangan lan pasar Akanda (AKAN)

- rega lan prakiraan konsensus rega:
Kutipan saham Akanda Corp|AKAN - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Kapitalisasi pasar Akanda Inc|AKAN - Nilai Total Perusahaan
- data kapitalisasi buku:
Nilai Buku saben Saham Akanda|AKAN - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku akandacorp.com|AKAN - Aset Agregat Perusahaan
- rincian utang lan likuiditas:
Rasio Utang marang Ekuitas Akanda|AKAN - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang modal akandacorp.com|AKAN - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Akanda Inc|AKAN - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Akanda|Rasio cepet akandacorp.com
- rincian bathi lan kelipatan pasar:
AKAN - Bathi resik|Proyeksi bathi mangsa ngarep Akanda|AKAN - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Akanda Inc|AKAN - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Akanda Inc|AKAN - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Akanda|AKAN - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan akandacorp.com|AKAN - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Akanda
Pambiji fundamental:Akanda
Produk merek Akanda Corp

Akanda investments in R&D and cannabinoid standardization determine the efficiency of monetizing its biotechnological potential. This indicator captures the annual change in earnings per share, measuring net income growth rates relative to the same period last year. By analyzing the percentage deviation of EPS from the previous year's level, an investor can verify the business's cyclical development stage and assess the sustainability of the company's market capitalization.

Pesaing langsung

Wutah bathi resik saben saham ing taun iki Indivior plc|COLL (Collegium Pharmaceutical Inc) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku Cronos Corp|Wutah bathi saben saham ing taun lumaku Canopy Growth (CGC)|Wutah bathi ing taun lumaku hightideinc.com (HITI)|Wutah bathi ing taun lumaku ACB (Aurora Cannabis Inc.)|Wutah bathi ing taun lumaku Achieve Life Sciences Inc. ACHV|SKYE - Wutah bathi saben saham ing taun lumaku|ANEB (Anebulo Pharma) - Wutah bathi saben saham ing taun iki|INCR: Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun iki NTRB|NSRX (Nasus Pharma Ltd.) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku IGC Pharma Inc|Wutah bathi ing taun lumaku MIRA|Wutah bathi ing taun lumaku Flora Growth Inc (FLGC)|Wutah bathi saben saham ing taun lumaku IM Cannabis IMCC|Wutah bathi ing taun lumaku Adial Pharmaceuticals Inc. ADIL|Artelo - Wutah bathi ing taun lumaku|ENSC - Wutah bathi ing taun lumaku|titanpharm.com (TTNP) - Wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun iki GNLN|Wutah bathi saben saham ing taun lumaku InMed Pharmaceuticals|Wutah bathi saben saham ing taun iki ENVB (enveric.com)|Wutah bathi ing taun lumaku BGXX|Wutah bathi ing taun lumaku Hempacco Co Inc. (HPCO)